Dose reduction of baricitinib in patients with rheumatoid arthritis achieving sustained disease control: results of a prospective study

T Takeuchi, MC Genovese, B Haraoui, Z Li… - Annals of the …, 2019 - ard.bmj.com
Objectives This study investigated the effects of dose step-down in patients with rheumatoid
arthritis (RA) who achieved sustained disease control with baricitinib 4 mg once a day …

[HTML][HTML] Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial …

KL Winthrop, CO Bingham, WJ Komocsar… - Arthritis Research & …, 2019 - Springer
Background Clinical guidelines recommend pneumococcal and tetanus vaccinations in
patients with rheumatoid arthritis (RA). Baricitinib is an oral, selective Janus kinase (JAK) …

Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional …

D van der Heijde, M Dougados, YC Chen… - RMD open, 2018 - rmdopen.bmj.com
Background Baricitinib was efficacious in a 24-week phase III study in patients with
rheumatoid arthritis (RA) and an inadequate response to conventional synthetic disease …

233 Durability, maintenance and effects of dose reduction following prolonged treatment with baricitinib

JS Smolen, M Dougados, T Takeuchi… - …, 2018 - academic.oup.com
Background: Baricitinib (BARI), an oral, selective Janus kinase (JAK) 1/JAK2 inhibitor, is
used for the treatment of moderately to severely active rheumatoid arthritis (RA) in adults. It …

[CITATION][C] Durability, maintenance, and effects of dose reduction following prolonged treatment with baricitinib

J Smolen, M Dougados, T Takeuchi… - Scandinavian …, 2018 - espace.library.uq.edu.au

[CITATION][C] Durability, Maintenance and Effects of Dose Reduction Following Prolonged Treatment with Baricitinib

S Josef, D Maxime, T Tsutomu, G Mark… - Swiss Medical …, 2018 - espace.library.uq.edu.au

[CITATION][C] Efficacy Response to Baricitinib Based on Baseline Characteristics in Patients Who Are Inadequate Responders to Conventional DMARD

M Dougados, TP Rooney, L Xie… - ARTHRITIS & …, 2017 - … ST, HOBOKEN 07030-5774, NJ USA

[CITATION][C] Dose Reduction of Baricitinib in Patients with Rheumatoid Arthritis Achieving Sustained Disease Control: Results of a Prospective Study

T Takeuchi, M Genovese… - JOURNAL OF …, 2018 - … PUBL CO 365 BLOOR ST E, STE …